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Abstract 
The Indigenous populations of Australia and New Zealand are considered at higher risk of mood and anxiety 
disorders but many studies do not include direct comparisons with similar non-Indigenous controls. We 
conducted a systematic search of relevant electronic databases, as well as snowballing and targeted searches of 
the grey literature. Studies were included for meta-analysis if they compared rates of mood and anxiety 
disorders between Indigenous and non-Indigenous Australians or Maori. Seven Australian and 10 NZ studies 
were included. Overall, Indigenous people in both countries did not have significantly higher rates of disorder. 
However, in terms of specific disorders, there were differences in risk by gender, country (Australia or NZ), 
disorder type, and prevalence (current, 12-month or lifetime). For instance, Indigenous Australians and Maori 
both had significantly lower rates of simple phobias (current prevalence) and Maori participants had 
significantly lower rates of both lifetime simple phobia and generalised anxiety disorders. By contrast, 
Indigenous Australians had significantly higher rates of bipolar affective disorder and social phobia (current 
prevalence). Generalisations regarding the risk of psychiatric disorders in Indigenous people cannot therefore 
be made as this varies by several factors. These include disorder type, sociodemographic factors, Indigenous 
origin and study method. 
 
Keywords: Australia; New Zealand; Indigenous; Maori; Aboriginal and Torres Strait Islander peoples; 
psychiatric disorders.  
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1. INTRODUCTION 
Australia and New Zealand’s (NZ) Indigenous populations, comprising Aboriginal and Torres Strait 
Islander (Indigenous Australians) and Maori peoples (respectively), have experienced significant disadvantage 
over the last 200 years. Indigenous Australians form approximately 3.0% of Australia’s population (Australian 
Bureau of Statistics, 2013), while Maori people form 14.9% of NZ’s population (Statistics New Zealand, 2013). 
These populations fare worse than their non-Indigenous counterparts in terms of both health  (Australian 
Bureau of Statistics, 2014; Ministry of Health, 2015) and life expectancy (Australian Institute of Health and 
Welfare, 2011; Statistics New Zealand, 2015). Further, both Indigenous Australian and Maori populations have 
higher rates of suicide (Australian Bureau of Statistics, 2012; Ministry of Health, 2011) and psychological 
distress (Australian Institute of Health and Welfare, 2011; Cunningham and Paradies, 2012; Gubhaju et al., 
2013; Ministry of Health, 2015), resulting in a  disproportionately high use of mental health services (Abas et 
al., 2003; Abas et al., 2008; Australian Institute of Health and Welfare, 2011).  
Given these findings, it is also likely that there are higher rates of formal psychiatric diagnoses in these 
groups. Whilst the physical health of these groups is well-understood, mental health is not as well-researched 
however. Previous reviews have attempted to identify rates of psychiatric disorders in Indigenous Australians 
(Black et al., 2015) and New Zealanders (Baxter, 2008), with varying findings. For instance, Black et al. found 
wide variability in the rates of psychiatric disorder for Indigenous Australians, with some studies reporting high 
rates (up to approximately 50% of participants) for anxiety and mood disorders. This variability was possibly 
due to varying samples (for example, community, medical, or corrections samples), as well as differences in 
design and methodology, measurement, and prevalence type (i.e., point, one year, or lifetime). No direct 
comparison was made between Indigenous Australians and similar non-Indigenous controls. 
Baxter’s (2008) review of Maori mental health literature determined that Maori also experienced high 
rates of disorder. Baxter presented studies making comparisons between Maori and non-Maori New Zealanders, 
finding that Maori were more likely to experience mood and anxiety disorders (some of which were 
significantly higher, depending on the disorder and study). However results were reported separately for the 
reviewed studies, and no statistical pooling was undertaken to determine generalisability across studies. 
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Neither of these reviews quantitatively analysed the data to determine if rates of psychiatric disorder 
were statistically greater than in similar non-Indigenous controls. This review aimed to address this gap by 
examining all available literature to determine the prevalence of common psychiatric (i.e., mood and anxiety) 
disorders in Maori and Indigenous Australian populations as compared to their non-Indigenous counterparts, 
with statistical pooling as appropriate.  
2. METHOD 
2.1. Inclusion and Exclusion Criteria 
Common Mental Disorders (CMDs) were examined. These include major depression, Generalised 
Anxiety Disorder (GAD), panic disorder, Obsessive-Compulsive Disorder (OCD), Post-Traumatic Stress 
Disorder (PTSD), and simple phobias (Kendrick and Pilling, 2012). Due to the focus on mood disorders, 
Bipolar Affective Disorder (BPAD) and dysthymic disorder were also included for analysis. These disorders 
were defined in accordance with diagnostic criteria specified by: the Diagnostic and Statistical Manual of 
Mental Disorders, 5
th
 Edition (DSM-5; American Psychiatric Association, 2013) or earlier versions of this 
manual; and the International Classification of Diseases, 10
th
 Edition (ICD-10; World Health Organization, 
1992).  
Studies were included for analysis if they met the following criteria:   
1. English-language, peer-reviewed empirical journal articles or government reports.  
2. Prevalence data was cited for common psychiatric disorders (mood and anxiety). This could be lifetime, 
12 month, or current prevalence. 
3. The sample comprised Indigenous Australian or Maori populations of any age, with a non-Indigenous 
comparison group from Australia or NZ (respectively). 
2.2. Search strategy 
Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA; see Figure 1; Moher et 
al., 2009) guidelines were followed. Articles published from 1994 to 2016 were included; this time frame was 
selected so as to be broad enough to capture as many papers as possible, and be consistent with the use of 
DSM-IV (American Psychiatric Association, 1994). Databases searched included PubMed, MedLine, 
CINAHL, Scopus, Web of Science, ScienceDirect, ProQuest Research Library, PsycInfo, PsycArticles, and the 
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Informit Indigenous and Health Collections (comprising the following databases: AMI; APAIS-Health; 
ATSIHealth; AUSPORT; AusportMed; CINCH-Health; DRUG, Health & Society; HIVA; Health Collection; 
RURAL; AEI-ATSIS; AGIS-ATSIS; AHB-ATSIS; AIATSIS; APAIS-ATSIS; Indigenous Australia; CINCH-
ATSIS; FAMILY-ATSIS; FNQ; Indigenous Collection; and MAIS-ATSIS). Keyword searches were conducted 
‘Across All Fields’ in electronic databases, and included the following:  
1. MEdical Subject Headings (MESH) term search: ‘Australia’ AND ‘Indigenous Population’ AND 
‘Mental Disorders’  
2. MESH: ‘New Zealand’ AND ‘Indigenous Population’ AND ‘Mental Disorders’ 
3. ‘Indigenous’ AND ‘Mental Health’ AND ‘Prevalence’ AND ‘Australia’ 
4. ‘Maori’ AND ‘Mental Health’ AND ‘Prevalence’ AND ‘New Zealand’ 
5. ‘Aboriginal’ AND ‘Psychiatric’ AND ‘Prevalence’ AND ‘Australia’ 
6. ‘Maori’ AND ‘Psychiatric’ AND ‘Prevalence’ AND ‘New Zealand’ 
All searches were conducted in 2016, with the most recent search conducted on 12
th
 July 2016.  
Retrieved results were imported into an Endnote x7 database (Thomson Reuters, 2013). Duplicate entries were 
removed with Endnote’s ‘Find Duplicates’ function, followed by a manual search through all papers to identify 
missed duplicates. Screening was then undertaken by reviewing titles and abstracts. Papers were then full text 
reviewed, and snowballing undertaken from the reference lists of included papers. Separate, targeted searches 
were also undertaken of the grey literature for relevant Australian and NZ government reports, as well as a 
search of the Cochrane Library. Papers retrieved through these targeted searches and snowballing were full text 
reviewed to determine eligibility for inclusion. Titles, abstracts, and papers were independently reviewed by 
two reviewers, as was data extraction and study quality (see below).  
2.3. Study quality 
The methodology of included studies was assessed using the model of Loney, Chambers, Bennett, 
Roberts, and Stratford (1998) . This model is designed to assess epidemiological studies examining prevalence 
or incidence of a given condition, and uses an eight point scale covering several methodological areas (e.g.: 
sampling method, frame, and size; response rate; and measures employed). The higher the score, the stronger 
the methodology. 
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In addition to assessing methodological quality according to Loney et al.’s (1998) method, possible 
socio-demographic differences between Indigenous and non-Indigenous participants were also considered. 
Where possible, subgroup analyses were undertaken to reduce potential confounding, and Indigenous/non-
Indigenous sociodemographic characteristics reported in studies were inspected; details are reported in 
subsequent sections.    
 
2.4 Statistical analysis 
Review Manager, version 5.3 (The Cochrane Collaboration, 2014), was used for statistical pooling of 
data extracted from studies. As studies were predominantly cross-sectional, odds ratios for dichotomous 
variables were calculated. Heterogeneity was assessed using the I² statistic; this indicates how widely the effect 
sizes vary. An I² outcome of ≥ 50% indicates likely heterogeneity, and scores in the range of 75 – 100% 
indicate considerable heterogeneity (Higgins and Green, 2011). As there was heterogeneity in some of the 
analyses, a random effects model was employed (as suggested by Higgins and Green, 2011). Heterogeneity was 
explored in subgroup analyses of individual disorders, gender, country/Indigenous origin, differences in 
comparison groups (NZ only), and study quality (with an outcome score of ≥ 5 on Loney et al.’s 1998 criteria 
used to indicate better quality studies); each individual study was also omitted in turn.  
Where there were an adequate number of studies (n ≥ 10), publication bias was assessed with two 
measures: funnel plot asymmetry and the fail-safe N statistic. These were calculated using Win-Pepi, version 
11.63 software (Abramson, 2011). 
3. RESULTS 
3.1. Included studies 
Seventeen papers were suitable for analysis (see Figure 1 for PRISMA outcomes).  Samples sizes varied 
greatly across studies, ranging from N = 146 to N = 40,333. Seven papers reported on Indigenous Australian 
participants (Table 1), and 10 papers on Maori (Table 2). Sample types also varied, with studies of: incarcerated 
people (k = 7, where k = number of studies; five of these were Australian studies); pregnant or postpartum 
women (k = 3); primary health care consumers (k = 3; all of these were NZ studies); the general population (k = 
1); people with diabetes (k = 1); Vietnam veterans (k = 1); and a birth cohort (k = 1).  
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Included studies predominantly reported crude prevalence rates, and two reported both unadjusted and 
adjusted rates. Excepting two studies, differences in sociodemographic characteristics of Indigenous and non-
Indigenous participants were considered. Typically, this was age and/or gender, although some studies reported 
greater detail (for example, marital status, education, employment status, household income, number of 
children, or offence history in prison samples). The studies that didn’t report these details were not intended as 
epidemiological studies: one aimed to validate a measure (Evans et al., 2010), and the other retrospectively 
examined PTSD within veterans (MacDonald et al., 1997).  
Specific to NZ, three studies compared Maori outcomes against NZ European participants (Evans et al., 
2010; Waldie et al., 2015; Webster et al., 1994); all other NZ studies used ‘non-Maori’ comparison groups, with 
three of these reporting that the non-Maori comparison group was predominantly NZ European.  
Study quality also varied widely, evidenced by methodology ratings from 1 – 8 (where 1 = minimum 
score and 8 = maximum score; Tables 1 - 2). Lower scores were sometimes because papers were not 
necessarily designed as epidemiological studies or to specifically measure the prevalence of CMDs. A range of 
diagnostic tools (n = 11) were used including structured and unstructured interviews, as well as questionnaires 
to assess specific disorders (such as depression; Tables 1 and 2). Fifteen studies reported on mood disorders, 
eight on anxiety disorders and five reported on any psychiatric disorder; varying prevalence rates (current, 12 
month, or lifetime) were however reported by different studies. The different CMDs are reported by their 
varying prevalence rates in Table 3.  
3.2. Meta-analyses 
3.2.1. Current prevalence.  
Eleven studies reported on the current prevalence of CMDs; the majority of these were for major 
depression (k = 10) (Table 3). Typically, there were no significant differences between Indigenous and non-
Indigenous people in rates of current disorders, although Indigenous people were significantly more likely to 
have a diagnosis of social phobia than controls, and significantly less likely to have a diagnosis of simple 
phobia (Table 3). Most of the comparisons showed evidence of heterogeneity apart from the following anxiety 
disorders where scores were less than 50%: OCD, panic disorder, and agoraphobia. Major depression however 
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had significant heterogeneity (I² = 86%). When studies on perinatal depression or depression comorbid with 
diabetes were excluded, the findings remained the same but heterogeneity was no longer significant.  
Sensitivity analyses were undertaken on a range of variables. Table 4 shows the results of subgroup 
analysis by gender. Indigenous females did not have higher rates of psychiatric disorder than non-Indigenous 
controls apart from one study that reported on broader classes of ‘Any Mood Disorder’ or ‘Any Psychiatric 
Disorder’ (Butler et al., 2007). Indigenous males were significantly more likely to have a diagnosis of Social 
Phobia than non-Indigenous males, but not any of the other disorders. None of these results showed 
heterogeneity.  
We also undertook a sensitivity analysis of studies with a better methodology (Arroll et al., 2009; Butler 
et al., 2007; Indig et al., 2010; Simpson et al., 2003); findings remained the same.  
Subgroup analysis was also undertaken on Indigenous origin (Maori or Indigenous Australian). 
Indigenous Australians were significantly more likely to have a diagnosis of BPAD (OR = 3.21, 95%CI = 1.34 
– 7.69, p <0.01) or social phobia (OR = 8.48, 95%CI = 1.54 – 46.5, p <0.01), but not other disorders. Maori 
people did not significantly differ from controls in rates of mood and anxiety disorders although one study 
however found that Maori participants were significantly more likely to have ‘Any Psychiatric Disorder’ than 
non-Maoris.  
Some of the NZ studies used different non-Indigenous populations as controls and so we investigated 
the effect of this on the results (Table 2). This was only possible in the case of major depression and when the 
comparison was restricted to just those of Caucasian origin (k = 3), Maori participants did have a significantly 
higher rate of major depression (OR = 1.88, 95%CI = 1.05 - 3.38, p <0.05). Another sensitivity analysis on 
major depression involved examining perinatal depression (k = 3). This determined that Indigenous women 
were significantly more likely to experience depression in the perinatal period (OR = 2.31, 95%CI = 1.90, 2.80, 
p <0.01). 
Finally, subgroup analysis was undertaken on studies that used prison samples (k = 6). Findings 
remained the same.  
 3.2.2. Twelve month prevalence.  
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Only three studies reported data on 12 month prevalence of CMDs (Table 3); all disorders that included 
more than one study had considerable heterogeneity (BPAD, Any Mood Disorder, Any Anxiety Disorder, and 
Any Psychiatric Disorder). Whilst Indigenous Australians and Maori were significantly more likely to have 
‘Any Anxiety Disorder’ (Table 3), this was not reflected in rates of individual anxiety disorders, and sensitivity 
analysis by Indigenous origin determined that this was actually not significant within Maori or Indigenous 
Australian populations separately. This is likely to be a function of low numbers of included studies within 
subgroup analysis.  
One study determined that Maori people were more likely to have ‘Any Psychiatric Disorder’ than 
controls (OR = 1.75, 95%CI = 1.58, 1.94, p <0.01)  (Baxter et al., 2006). Again, this however was not reflected 
in rates of individual disorders. Baxter et al.’s measurement of ‘Any Psychiatric Disorder’ included mood, 
anxiety, eating, and substance use disorders; rates reported for substance use disorders were higher for Maori 
participants than controls, which may account for this discrepancy.  
No further subgroup comparisons were able to be undertaken, due to the low number of included studies 
for 12 month prevalence (see Table 3 for numbers of included studies per disorder).  
 3.2.3. Lifetime prevalence.  
Indigenous people did not have significantly higher rates of any lifetime CMD than non-Indigenous 
people (Table 3). PTSD and ‘Any Psychiatric Disorder’ comparisons had considerable heterogeneity, whilst 
other anxiety and all mood disorders had nil or negligible variations (see Table 3 footnote). Due to this 
heterogeneity, sensitivity analysis was undertaken on studies with a higher methodology rating and Indigenous 
origin. 
Sensitivity analysis of better quality studies (Arroll et al., 2009; Baxter et al., 2006; Butler et al., 2007; 
Marie et al., 2008; Simpson et al., 2003) revealed that Maori participants were significantly less likely to have 
simple phobia (k =1; OR = 0.75, 95%CI = 0.57, 1.00; p = 0.05) or GAD (k = 1; OR = 0.38, 95%CI = 0.14, 0.99; 
p = 0.05) than controls, according to Simpson et al. (2013). In contrast, ‘Any Anxiety Disorder’ was 
significantly elevated in Maori people (k = 1; OR = 1.59, 95%CI = 1.04, 2.44; p < 0.05), according to Marie et 
al. (2008). These discrepant results are likely to be a function of the different samples employed (Evans et al. 
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recruited incarcerated Maori males; Marie et al. examined young people within a birth cohort of young people), 
different diagnostic instruments used, and different anxiety disorders assessed. 
Subgroup analysis by Indigenous origin determined that Indigenous Australians did not differ from 
controls in disorder prevalence. Heterogeneity was present in disorders that included more than one study for 
comparisons: ‘Any Anxiety Disorder’, I² = 70%, and ‘Any Psychiatric Disorder’, I² = 94%. Analysis by Maori 
origin resulted in findings reported in the preceding paragraph (i.e., significantly lower rates of GAD and 
simple phobia, yet significantly higher rates of ‘Any Anxiety Disorder’).  
3.3. Publication Bias  
Major depression (current prevalence) was the only CMD with sufficient studies to assess for 
publication bias. The fail-safe N statistic indicated that 20 studies with null findings would be required in order 
to reduce the overall ratio to a negligible size (i.e., a weighted odds ratio of 1.1). The funnel plot did not have 
significant asymmetry (p = 0.47). Given that double the current studies are required to make the current effect 
size negligible and the large p value, it is likely these results were relatively safe from publication bias.  
4. DISCUSSION 
To our knowledge, this is the first meta-analysis that compares rates of common psychiatric disorders in 
Indigenous populations across Australia and New Zealand with those of non-Indigenous people from the same 
two countries. We only included research that assessed both groups within the same study, using the same 
instruments and methodology. It was unexpected that mood and anxiety disorders in general were not elevated 
for Indigenous Australian and Maori populations, given the context of elevated rates of mental health service 
usage (Abas et al., 2003; Abas et al., 2008; Australian Institute of Health and Welfare, 2011), psychological 
distress (Australian Institute of Health and Welfare, 2011; Cunningham and Paradies, 2012; Gubhaju et al., 
2013; Ministry of Health, 2015), alcohol and/or substance use (Baxter et al., 2006; Indig et al., 2010; Indig et 
al., 2011; Marie et al., 2008; Simpson et al., 2003), hospitalised rates of self-harm (Ministry of Health, 2011; 
Steering Committee for the Review of Government Service Provision, 2014), and suicide in these groups 
(Australian Bureau of Statistics, 2012; Ministry of Health, 2011). Whilst unexpected, these findings are 
consistent with research outcomes in other Indigenous populations, where similar or lower rates of CMDs have 
also been found. For example, a large study recruiting two Native American tribes (N = 3,084) found noticeably 
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lower rates of major depression as compared to the general American population (Beals et al., 2005). Another 
study found that after adjusting for covariates (such as gender and parental education), Canadian Aboriginal 
status was not significantly linked to depressed mood in a large sample of young people (N= 4,093; Lemstra et 
al., 2008). These results may therefore reflect genuine outcomes where Indigenous people are not at 
significantly higher risk of some psychiatric disorders than other groups. It may be that despite significant 
disadvantage, Indigenous culture actually forms a protective factor against psychiatric disorders: research has 
found that for Maori people, connection to culture is linked to greater resilience (Muriwai et al., 2015) and 
subjective well-being (Houkamau and Sibley, 2011). Further, research has found that living in areas of higher 
ethnic density is linked to better health outcomes, such as lower diagnosed psychiatric disorders and higher 
self-reported health in Maori people (despite deprivation in these regions; Bécares et al., 2013) and less 
psychological distress in Indigenous Australian people (Cunningham and Paradies, 2012). Interestingly, 
Bécares et al.’s study found that psychological distress was highest in areas of higher deprivation- these areas 
also happened to have higher Maori density, and lower rates of psychiatric disorders. Therefore, Indigenous 
people may experience higher rates of psychological distress and associated variables due to factors unrelated 
to ethnicity, but potentially lower rates of disorders as a result of cultural connection or density. This hypothesis 
may also account for the sensitivity findings that Indigenous Australians had significantly higher rates of some 
disorders, whilst Maori people had significantly lower rates of some disorders. Maori people comprise a larger 
proportion of NZs’ population than Indigenous Australians in Australia’s population (14.9% vs 3.0% , 
respectively; Australian Bureau of Statistics, 2013; Statistics New Zealand, 2013). However, it is also possible 
that differences in cultures, customs, and histories could also influence these outcomes.  
Another explanation for the lack of difference in psychiatric morbidity may be that the assessment tools 
used in these studies, or diagnoses derived from ICD or DSM, may not accurately measure psychiatric 
symptoms in Indigenous populations. For instance, sadness and low mood may be more typical of anxiety 
rather than depressive disorders in Indigenous young people (Thomas et al., 2010). Depression may also present 
differently with anger or substance misuse predominating over low mood and somatic symptoms (Brown et al., 
2012; Thomas et al., 2010). Anger and reckless behaviour, in the absence of low mood or somatic symptoms, 
may explain both the significantly higher rates of BPAD in this group, and the equivalent or significantly lower 
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rates of major depression in Indigenous participants. Further exploration of how CMDs present in Maori and 
Indigenous Australians is warranted to clarify potential cultural differences in CMD presentation and how this 
influences diagnostic prevalence.  
Another factor influencing prevalence may be the types of samples recruited. Included studies typically 
consisted of specific samples, such as incarcerated people, primary health care attendees, and 
pregnant/postpartum women. Only two studies could be considered representative of the community: both of 
these were in NZ, with one epidemiological study and one birth cohort study. Sensitivity analysis indicated that 
findings generally remained consistent by setting, although Maori and Indigenous Australian women in the 
perinatal period were significantly more likely to experience depression than their non-Indigenous counterparts. 
However, in the case of social phobia such an analysis was not possible: there was only one study and this was 
of a prison sample. It is therefore possible that the significantly higher rates of social phobia may be an artefact 
of that particular setting. Given these specific samples, it is unclear whether the results of the current study are 
applicable to the broader Indigenous Australian and Maori communities. 
It is also unclear why instruments would fail to detect disorders such as major depression, but not others 
such as social phobia. Complicating this picture further is evidence that psychotic disorders are also elevated in 
Indigenous Australians (Butler et al., 2007; Indig et al., 2011) and Maori (Evans et al., 2010), as compared to 
controls. Differences may therefore be disorder-specific. 
In summary, several explanations may account for the current study’s findings, including cultural 
differences, differences between internalising/externalising disorders, and genuine outcomes. What makes this 
picture more complex however is that findings were not uniform, so that no explanation accounts for all 
outcomes. Different patterns in findings were obtained across type of prevalence assessed, which may be due to 
different studies and methods being included for current, 12 month, and lifetime prevalence. This is further 
supported by high heterogeneity in some of the comparisons. When this was explored further in subgroup 
analyses, possible explanations included differences by Indigenous group (Indigenous Australian or Maori), 
gender, and individual disorders measured and included. Twelve month prevalence was also not as well-
researched as current and lifetime prevalence, with a lesser number of included studies.  
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Finally, the type of comparison group employed may also influence research outcomes. Whilst 
conducted on current prevalence only, a sensitivity analysis found that Maori people had higher rates of major 
depression when compared to only NZ European participants, but not when the comparison group comprised 
other ethnicities; this occurred even when the comparison group was predominantly NZ European. This 
indicates that another ethnic group may be influencing these outcomes. For example, research has identified 
that Pacific Islanders have higher rates of psychiatric disorder than the general NZ population (Foliaki et al., 
2006); it may be that including this population in non-Maori comparison groups obscures potential significant 
outcomes. Future research therefore needs to consider the ethnic make-up of comparison groups when 
researching Maori and Indigenous mental health.  
4.1 Limitations 
This study had several limitations. Firstly, although Indigenous and non-Indigenous participants came 
from the same setting in each study, it is possible that sociodemographic differences between these populations 
(such as age, gender, employment, educational status, or even differences in the comparison group recruited) 
could confound these results. Further, included studies typically used specific populations, which may not be 
representative of the broader Indigenous communities. This risk was managed by undertaking subgroup 
analyses on a range of variables; and, given the marginalisation of many Indigenous Australian and Maori 
people, any bias would be in the direction of increasing their risk of psychiatric disorders. This does not explain 
several findings that the risk was often the same between groups, or even significantly lower for some 
disorders. 
Some results showed heterogeneity, which was explored further in several sensitivity analyses. 
Differences in sociodemographic variables within the Indigenous and comparison groups influenced outcomes. 
Omitting each study in turn made little difference to heterogeneity levels. Accordingly, a random-effects model 
was used throughout to incorporate heterogeneity into the analyses. Despite attempts to minimize heterogeneity 
effects, analyses where this was present should still be treated cautiously. Finally, publication bias was only 
able to be assessed in current major depression; whilst this was low risk for bias, the same may not be true of 
other comparisons.  
4.2. Conclusions 
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Generalisations regarding risk of psychiatric disorders cannot be made for Indigenous people as whole, 
as risk varies by disorder type, sociodemographic factors, Indigenous origin, study method, and even 
comparison group recruited. Research that further attempts to elucidate the impact of such variables on CMD 
rates is indicated. Another factor that may influence outcomes is culture itself. For instance, resilience may be 
enhanced when Indigenous people live in close proximity with numbers of other Indigenous people. 
Epidemiological research that examines variations in rates of CMDs by region, ethnic density, and cultural 
connection is warranted. 
This review also identified a lack of representative community studies, particularly for Australia. 
Epidemiological research within Maori and Indigenous Australian community samples is required in order to 
gain accurate understanding of disorder rates.  
Finally, current measurement of psychiatric disorders may not accurately capture the expression of these 
disorders in Indigenous populations, explaining why some analyses found non-significant, or significantly 
lower rates of some disorders in Indigenous people. Future research is therefore required that examines the 
cross-cultural validity of psychiatric constructs and diagnostic instruments, in order to avoid misdiagnosis and 
false negatives.  
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Keyword searches 
returned 6785 
articles 
k = 205 articles 
excluded 
k = 4807 excluded 
k = 1757 duplicates 
removed 
k = 16 articles 
included   
Full text review of  
k = 221 
Title and abstract 
review of k = 5028 
Duplicates removed, 
leaving k = 5028 
k = 44 articles 
obtained through 
snowballing and a 
targeted search 
k = 17 articles 
retained for analysis:   
7 Australian 
10 New Zealand 
k = 43 articles 
excluded through 
full text review; 1 
included  
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 Fig 1. Literature Search Strategy. 
 
 
 
Table 1 Studies reporting prevalence of common psychiatric disorders for Indigenous People 
of Australia 
Study  
 
N      Assessment
a
 Sample 
Characteristics
b
 
Sampling strategy
 c
  Methodology rating
d
 
and Limitations: 
A. Study-identified 
B. Review-identified 
Butler et 
al. 
(2007) 
1,470 A range of 
measures (not all 
diagnostic); 
notably, the 
Composite 
International 
Diagnostic 
Interview (CIDI; 
World Health 
Organization, 
1993). 
 
  
 
Mixed sample of 
Indigenous and 
non-Indigenous 
Australian 
prisoners 
(sentenced and in 
reception).   
Indigenous 
participants (n = 
277), with 81.6% 
male (n = 226), 
and 18.4% female 
(n = 51). 
Data on sentenced 
prisoners came 
from the 2001 
Inmate Health 
Survey that was 
also used by Indig 
et al (2010; see 
below) but studies 
reported on 
different outcomes 
 
Study occurred across 
all 29 Correctional 
centres in New South 
Wales (NSW).  
Stratified random 
sample of sentenced 
prisoners, and 
convenience sample 
of reception 
prisoners. 
Recruitment rate of 
85%.  
5/8 
 
A. Authors discuss 
the population 
sampling intended of 
reception prisoners 
not feasible (due to a 
variety of factors), so 
relied on convenience 
sampling in this area 
(not representative). 
Authors queried the 
validity of the OCD 
diagnosis in 
Indigenous 
Australians.   
 
B. Psychosis screener 
used, therefore not 
diagnostic.  Measures 
not validated for 
Indigenous people. 
Very specific 
population (in 
detention) means 
results not 
generalisable to 
broader community.  
There was no 
information on 
demographic 
differences between 
ethnic groups. Results 
were reported 
                                                          
a
 This column considers how the disorders were assessed or measured, and the tools used for this.  
b
 Sample characteristics described, including ethnicity, gender, age (range and mean), and location. 
c
 The sampling and recruitment strategy used by the study are briefly described, as well as the location of the 
study and sample type. 
d
 This was done using Loney et al.’s criteria, which assign a score out of 8. Criteria used include: design and 
sampling method, size, and frame; response rate; participant description; measurement of the health outcome, 
and potential for bias; and the provision of confidence intervals and subgroup detail when prevalence or 
incidence is reported. 
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separately for males 
and females. 
Davis et 
al. 
(2015) 
900 Nine-item 
Personal Health 
Questionnaire 
(PHQ-9) 
People with 
diabetes living in 
the community 
 
n = 52 Indigenous 
Australian 
participants 
completed the 
PHQ-9 (overall 
study had n = 107). 
 
Anglo-Celt n = 
793; although n = 
772 completed the 
PHQ-9. 
Anyone in the study 
catchment area with a 
clinician-verified 
diagnosis of diabetes 
was eligible. 
Recruitment was 
through public 
hospital clinics, 
laboratories, clinician 
referrals, 
advertisements in 
pharmacies and local 
media, as well as 
mail-outs through the 
Australian National 
Diabetes Supply 
Scheme and National 
Diabetes Register. In 
addition, an 
Aboriginal health 
worker identified and 
recruited indigenous 
patients. 
 
4/8 
 
A. Low numbers of 
Indigenous 
participants  
 
B. The sample was 
restricted to people 
with diabetes and 
depressed mood was 
assessed by a 
questionnaire.  
Doolan 
et al. 
(2012) 
3,705  Diagnostic 
Interview based on 
ICD-10 criteria 
administered by 
experienced and 
trained clinicians, 
and discussed with 
Consultant 
Psychiatrist during 
a team meeting. 
Indigenous 
Australians formed 
46% of sample (n 
= 1696); the rest 
were non-
indigenous 
participants. 
Indigenous 
females were 
25.4% (n = 430) of 
Indigenous sample, 
males 74.6% (n = 
1266).  Age range 
10 - 21 years. 
Recruited from a 
Youth Detention 
Centre from those 
referred to the Mental 
Health Alcohol 
Tobacco and Drugs 
service.  Only 1091 
Indigenous 
Australian 
participants attended 
the diagnostic 
interview: Males 
(78.1%; n = 852); 
Females (21.9%; n = 
239). Response rate 
for males = 69.2%, 
females = 60.1% 
4/8 
 
A. Only people 
referred to the service 
were assessed; this 
could lead to bias as 
potentially there are 
people with 
psychiatric disorders 
who may not be 
referred to the 
service. Attrition also 
present in sample 
through people being 
released prior to 
interview.  
 
B. Very specific 
population (in 
detention) means 
results not 
generalisable to 
broader community.  
Specific diagnoses 
not reported. Lower 
than ideal response 
rate. 
There was no 
information on 
demographic 
differences between 
ethnic groups. Results 
were reported 
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separately for males 
and females.  
Fleming 
et al. 
(2012) 
146 
 
Participants self-
reported treatment 
for diagnoses on 
the survey 
instrument 
(administered via 
interview). 
Participants were 
recruited from two 
WA maximum 
security prisons. 
43 participants 
were Indigenous 
Australian, with 21 
females (49%) and 
22 males (51%). 
Further 
Indigenous-
specific 
demographics not 
reported.  
Participants in the 
study approximated 
18% of the 
population in the two 
prisons. Information 
sources such as peer 
support officers and 
flyers promoted the 
project; participants 
volunteered and were 
then screened for 
inclusion. 
1/8 
 
A. Small number of 
participants 
acknowledged as not 
being generalisable. 
Identified that 
Indigenous 
Australians were 
under-represented in 
the study. 
B. Small number of 
Indigenous 
participants means 
results are limited. 
Self-report data can 
be biased; study was 
not diagnostic. 
Sampling strategy 
could also bias 
results. 
There was no 
information on 
demographic 
differences between 
ethnic groups. Results 
were reported 
separately for males 
and females. 
Indig et 
al. 
(2010) 
 
996 
 
 
 
 
 
 
 
 
 
 
 
914 
789 
Computer-assisted 
telephone 
interview; physical 
health 
examination; and a 
range of 
questionnaires, 
notably  
Beck Depression 
Inventory- II 
(BDI-II; Beck et 
al., 1996). 
 
 
 
2009 Inmate 
Health Survey -
Mixed sample. Of 
incarcerated 
Indigenous 
Australians (n = 
312), 83% were 
male (n = 259) and 
17% female (n = 
53). Six percent 
identified as TSI.  
Average age was 
35.5 years, with 
females (M = 31.1 
years) and males 
Stratified (by age, 
gender, and 
Indigenous status) 
random sampling 
occurred across all 
correctional centres 
in NSW (n = 30): 26 
male centres and 4 
female centres. 
Response rate was 
85.4% (1128 inmates 
were approached).  
 
6/8 
 
A. The authors note 
that only a small 
sample of Indigenous 
women were 
recruited, so these 
results are not 
representative. 
 
B. There was no 
information on 
demographic 
differences between 
ethnic groups other 
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As above 
 
(M = 34.1 years).  
2001 Inmate 
Health Survey 
1996 Inmate 
Health Survey 
than the Indigenous 
group in the 2009 
Inmate Health Survey 
was significantly 
younger. Results were 
reported separately 
for males and 
females. 
Indig et 
al. 
(2011) 
361 A health survey 
with physical 
examination, and 
psychological 
assessments, 
including the 
Kiddie Schedule 
for Affective 
Disorders for 
Children-Present 
and Lifetime 
version. 
2009 Young 
People in Custody 
Health Survey.  
Overall, 174 
Indigenous young 
people 
participated; 
however only 140 
completed the 
psychological 
assessments. 
Age range was 13 
– 21 years (M = 
16.7 years). 
Survey conducted at 
8 juvenile justice 
centres and 1 juvenile 
correctional centre in 
NSW. Over-sampling 
used at female centre 
to increase number of 
female participants.  
All incarcerated 
young people on the 
first day at the 
location were 
approached. 
Response rate was 
95%. The total 
sample represented 
80% of all 
incarcerated young 
people. 
4/8 
A. Parental 
component of 
diagnostic schedule 
not administered. 
Interrater reliability 
not assessed.  Study 
relied on self-report 
rather than using a 
range of strategies 
(e.g., medical records, 
parent report). 
Possible fatigue 
effects are 
acknowledged due to 
the battery of 
measures. Small 
number of females 
recruited. Not all 
measures have been 
validated for 
Indigenous 
populations. 
B. The Indigenous 
group was a small 
sample. There was no 
information on 
demographic 
differences between 
ethnic groups 
Milgrom 
et al. 
(2008) 
40,333 Edinburgh 
Postnatal 
Depression Scale, 
along with other 
screening 
measures. This 
assessed both 
Antenatal and 
Postnatal 
Depression; only 
the Antenatal rates 
are reported due to 
Indigenous 
statistics not being 
reported for 
Postnatal 
Depression. 
Prospective 
Australian sample 
of pregnant 
women, assessed 
antenatally and 6 
weeks postpartum 
for depression. 
 
In the Antenatal 
Depression 
sample: 
Non-Indigenous n 
= 12,139 
Indigenous 
Australians n = 
222 
 
 
Midwives in hospitals 
across Australia 
recruited participants. 
Details not reported. 
3/8 
 
A. Not all pregnant 
women participated 
in the study; and there 
was an attrition rate 
of just over 50% for 
women followed up 
(for those that 
received follow-up). 
 
B. Use of 10 item 
screening tool for 
diagnosis. Lacks 
recruitment details. 
Prevalence rates 
across Indigenous/ 
non-Indigenous 
groups only reported 
for antenatal 
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depression, not 
postnatal depression. 
 
Table 2 Studies reporting prevalence of common psychiatric disorders in Indigenous People of New Zealand 
Study  
 
N      Assessment
a
 Sample 
Characteristics
b
 
Sampling strategy
 c
  Methodology rating
d
 and 
Limitations: 
A. Study-identified 
B. Review-identified 
Arroll et al. 
(2009) 
7432 
 
Computerised CIDI 
PHQ also completed by 
one third of sample 
 
 
People accessing 
their GP (N = 
7432). 
 
Non-Maori n = 
6711. 
Maori n = 721 
Maori mean age 
was 39 years, with 
62% of sample 
female (n = 449).  
 
General Practitioners 
(GPs) in Auckland 
were recruited to ask if 
their patients were 
interested in the study. 
GPs needed to work 
above 0.4FTE and 
have an interview 
room available for the 
study. 
Patients were then 
approached in the 
waiting room, 
informed consent 
sought, and CIDI 
interview conducted.  
 
5/8 
 
A. Medical practices were 
not randomly chosen- they 
required available 
interviewing rooms for the 
study. Study may be 
underpowered. CIDI has 
been criticised. Different 
prevalence rates obtained 
to prior research in primary 
care.  
 
B. As participants recruited 
from primary care, which 
the authors acknowledge 
have higher prevalence 
rates than in the 
community, findings not 
representative of Maori 
generally.  
Arroll et al. 
(2002) 
253 BDI  People attending 
their GP (N = 253); 
ranged in age from 
16 - 95 years.  
 
Maori n = 64 
Non-Maori n = 189 
 
Conducted at a 
medical centre in 
Auckland. GPs asked 
all consecutive 
patients aged ≥16years 
if they would 
complete a survey 
about their health and 
mood post-
consultation. Those 
who consented were 
referred to the study’s 
interviewer.  
3/8 
 
A. Authors state that use of 
BDI is a weakness, as the 
gold standard for 
measuring depression is 
psychiatrist interview. 
 
B. Small sample that is 
specific to one medical 
practice. Interviewer not 
blinded to GP’s opinion as 
to whether patient 
depressed or not. 
Questionnaire self-
administered, which relies 
on literacy skills.  
  
Baxter et al. 
(2006) 
12,992 
(Part 1) 
 
7435 (Part 
2) 
CIDI, broken into two 
parts to reduce 
participant burden. 
 
Part 1 involved screening 
of all mental disorders, 
diagnostic assessment of 
mood and anxiety 
disorders (excepting 
PTSD, OCD). Those 
with no disorders at the 
end of Part 1 were not 
invited back to complete 
Part 2, except for a 
probability subsample.  
The New Zealand 
Mental Health 
Survey 2003-2004.  
General population 
≥16 years  
 
Maori n = 2595; of 
which females 
53.4%, males 
46.6% 
Pacific Islanders n 
= 2236 
‘Other’ 
(predominantly NZ 
European origin) n 
Face to face survey of 
households; nationally 
representative.  
 
 
8/8 
 
A. The authors suggest that 
using standardised western 
tools cross-culturally may 
not appropriately capture 
all expressions of the 
disorder. 
 
B. Part 1 and Part 2 
findings reported in an 
unclear manner so it is 
unknown which sample 
formed the findings at any 
given time.  
                                                          
a
 This column considers how the disorders were assessed or measured, and the tools used for this.  
b
 Sample characteristics described, including ethnicity, gender, age (range and mean), and location. 
c
 The sampling and recruitment strategy used by the study are briefly described, as well as the location of the study and sample type. 
d
 This was done using Loney et al.’s criteria, which assign a score out of 8. Criteria used include: design and sampling method, size, 
and frame; response rate; participant description; measurement of the health outcome, and potential for bias; and the provision of 
confidence intervals and subgroup detail when prevalence or incidence is reported. 
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Study  
 
N      Assessment
a
 Sample 
Characteristics
b
 
Sampling strategy
 c
  Methodology rating
d
 and 
Limitations: 
A. Study-identified 
B. Review-identified 
 
Part 2 involved assessing 
PTSD, OCD, and SUDs. 
 
= 8161 
Evans et al. 
(2010) 
1292 
screens 
completed 
530 MINI 
completed 
Initial screening 
measures included the 
Brief Jail Mental Health 
Screen and English 
Mental Health Screen. 
All positive screens, and 
a proportion of negative 
screens, completed the 
Mini International 
Neuropsychiatric 
Interview.  
 
New male prisoners 
admitted to 
Christchurch’s 
Men’s Prison, 
Auckland Central 
Remand, and 
Mount Eden Prison. 
 
Of the screens 
completed, n = 546 
were NZ European 
and n = 440 were 
Maori. 
 
Of the 530 MINI 
completed, n = 229 
NZ European and n 
= 187 Maori.  
All new admissions 
assessed with the brief 
screens. Those with 
positive results, and 
20% of negative 
screens were invited to 
participate in the 
MINI (which had a 
92% response rate).  
4/8 
 
A. Only male prisoners 
recruited. Structured 
diagnostic tool used instead 
of an experienced clinician 
may undermine validity of 
the measure. Self-harm 
in/out of prison not 
differentiated. 
 
B. Unclear if lay 
interviewers were used 
instead of clinicians, and if 
MINI interviewers were 
blinded to the screen or 
not. Small number of 
Maori who completed the 
diagnostic measure.  
 
MacDonald 
et al. (1997) 
756 Self-report 
questionnaires employed: 
the Mississippi Scale (for 
PTSD); the BDI 
(Depression); and 
subscale of the State-
Trait Anxiety Inventory 
(Anxiety). Demographic, 
military experience, and 
trauma exposure 
questions also included.  
Known Vietnam 
veterans invited to 
participate.  
 
22% were Maori (n 
= 166) 
78% non-Maori (n 
= 590) 
 
Questionnaires were 
mailed to known 
Vietnam veterans on a 
random basis from a 
Ministry of Defence 
list; however this was 
approximately 50% of 
this population, due to 
not having a national 
registry of veterans.  
0/8 
 
A. Low response rate and 
therefore not able to 
determine sample bias 
present; non-random 
sample; relies on 
retrospective reporting. 
Assessment of PTSD not 
the standard (i.e., self-
report questionnaire used). 
Number of Maori soldiers 
thought to be under-
represented in the sample; 
although Maori n is 
oversampled when 
compared to community 
Census data.  
 
B. Findings not 
representative of veterans 
due to sampling frame 
limitations and low 
response rate. Low number 
of Maori participants.  
 
Marie et al. 
(2008) 
984 CIDI supplemented by 
questions using DSM-IV 
criteria for a range of 
disorders 
Birth cohort up to 
the age of 25 years; 
part of the 
Christchurch Health 
and Development 
Study.  
 
Non-Maori n = 875 
 
Initial cohort 
comprised all births in 
Christchurch in a 
certain time period (N 
=1310; 1265 agreed to 
be part of the study). 
80% of the original 
sample retained for 
this study.  
6/8 
 
A. Birth cohort specific to 
one region and time frame, 
therefore generalisability 
unclear. Small number of 
Maori participants.  
 
B. Given the young age of 
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Study  
 
N      Assessment
a
 Sample 
Characteristics
b
 
Sampling strategy
 c
  Methodology rating
d
 and 
Limitations: 
A. Study-identified 
B. Review-identified 
Sole Maori identity 
n = 50 
 
Maori/Other 
identity n =  59 
the sample, this won’t 
indicate prevalence of 
disorders across the 
lifespan. Information 
lacking on administration 
of measures and by whom.  
 
Simpson et 
al. (2003) 
1287 CIDI and the Personality 
Diagnostic Questionnaire 
for DSM-IV  
 
National Study on 
Psychiatric 
Morbidity in NZ 
Prisons 
Maori over-
represented.  
Maori n = 622 
Pacific Islander n = 
107 
NZ European n = 
398 
Other n = 158 
 
 
All prisons in NZ 
sampled- all female 
prisoners and all male 
remand prisoners 
approached. For 
sentenced male 
prisoners, a random 
sample was 
approached.  
6/8 
 
A. Risk of committing 
cross-cultural error in 
diagnosis as diagnostic tool 
not validated for Maori. 
Maori response rates not 
recorded (refuser 
characteristics not 
documented).   
 
B. Variety of interviewers 
employed (including 
experienced clinicians, 
psychology interns, and lay 
interviewers). Inter-rater 
reliability not assessed.  
 
The MaGPIe 
Research 
Group 
(2005) 
786 Initial screen with GHQ 
by GP; subset (n = 786) 
invited back to complete 
CIDI  
Primary care 
patients aged ≥ 18 
years.  
GHQ score 
determined who 
was invited to 
participate in CIDI. 
 
Maori n = 81 
Non-Maori n = 705 
70 randomly selected 
GPs from a region in 
NZ were invited to be 
part of the study. 50 
consecutive patient 
GHQ screens 
completed on people 
about to consult their 
GP. GHQ score used 
to select CIDI sample.  
 
4/8 
 
A. Low number of Maori 
participants; diagnostic 
interview not validated for 
use with Maori people; not 
representative of a 
community sample. 
 
B. Study methodology 
lacks detail. 
 
Waldie et al. 
(2015) 
5664 EPDS, to assess for 
antenatal depression 
Pregnant women 
participating in the 
Growing Up in NZ 
longitudinal cohort 
study. Recruited 
from a region in NZ 
with due dates from 
2009-2010. 
 
Ethnicity data 
available for N = 
5656.  
Maori n = 747 
NZ European n = 
3168 
Pacific Islander n = 
726 
Asian n = 802 
Other n = 213 
Participants initially 
invited to participate 
by their midwife, 
physician, or 
obstetrician. Media 
and community 
organisations used to 
inform eligible women 
of the study. 
Recruiters also 
attended hospitals and 
antenatal clinics. 
 
 
 
 
 
 
 
3/8 
 
A. Measure able to be 
employed were limited by 
feasibility within the large 
sample. Diagnostic validity 
of EPDS within sample is 
lacking.  
 
B. Use of a 10 item 
screening measure for 
diagnosis of depression.  
 
Webster, 
Thompson, 
Mitchell, 
206 EPDS, to assess postnatal 
depression 
 
Women who gave 
birth to a live baby 
in hospital.  
All women who had a 
baby in Auckland over 
a 1 week period; they 
2/8 
 
A. Time frame used may 
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Study  
 
N      Assessment
a
 Sample 
Characteristics
b
 
Sampling strategy
 c
  Methodology rating
d
 and 
Limitations: 
A. Study-identified 
B. Review-identified 
and Werry 
(1994) 
Small, random 
subsample also 
completed a semi-
structured interview 
based on DSM-III 
depression criteria. 
 
Maori n = 42 
NZ European n = 
163 
 
 
were assessed at four 
weeks postpartum.  
 
have resulted in women 
with resolving adjustment 
disorders being diagnosed 
with depression, and may 
have missed other cases 
that later went on to 
develop depression.  
 
B. Use of a 10 item 
screening measure to 
diagnose depression. Small 
number of Maori 
participants.  
 
Note. BDI = Beck Depression Inventory; CIDI = Composite International Diagnostic Interview; PHQ = Patient Health Questionnaire; 
GHQ = General Health Questionnaire; EPDS = Edinburgh  Postnatal Depression Scale. 
 
 
 
 
  
Table 3 Current, 12 month, and lifetime prevalence of common psychiatric disorders in Indigenous people of 
Australia and New Zealand  
  Current   12 
month 
   Lifetime  
 k
a
 N  Odds Ratio 
[M-H, 
Random, 
95% CI] 
k N Odds Ratio 
[M-H, 
Random, 
95% CI] 
k N Odds Ratio 
[M-H, 
Random, 
95% CI] 
Mood Disorder          
Major depression 10 25,826 1.21 [0.89, 
1.65] 
 
1 1,478 0.71 [0.48, 
1.06] 
 
6 20,789 1.09 [0.90, 
1.32] 
 
Dysthymic disorder 2 2,656 0.83 [0.34, 
2.05] 
 
1 1,478 1.14 [0.68, 
1.90] 
 
1 1,178 0.95 [0.57, 
1.57] 
 
BPAD/mania/hypomania 3 3,072 1.45 [0.68, 
3.10] 
 
2 4,220 1.92 [0.98, 
3.74] 
 
2 1471 0.81 [0.42, 
1.56] 
 
Any Mood Disorder 1 1,478 1.06 [0.74, 
1.51] 
 
3 13,020 1.86 [0.92, 
3.76] 
 
1 293 0.86 [0.50, 
1.48] 
 
Anxiety Disorder          
GAD 2 2,656 0.51 [0.09, 
2.97] 
 
1 1,478 1.17 [0.82, 
1.67] 
 
2 1,471 0.56 [0.27, 
1.19] 
 
Panic disorder 2 2,656 1.13 [0.71, 
1.80] 
 
1 1,478 1.27 [0.83, 
1.95] 
 
1 1,178 0.67 [0.41, 
1.10] 
 
OCD  2 2,656 1.18 [0.70, 
1.98] 
 
1 1,478 1.09 [0.47, 
2.52] 
 
2 1,471 0.86 [0.56, 
1.33] 
Agoraphobia 2 2,656 1.13 [0.47, 
2.74] 
 
1 1,478 1.65 [0.84, 
3.25] 
 
1 1,178 1.65 [0.89, 
3.07] 
 
Social phobia 1 1,478 8.48 [1.54, 
46.51]** 
 
1 1,478 1.29 [0.42, 
3.99] 
 
1 293 1.56 [0.48, 
5.03] 
 
PTSD 2 2,656 0.94 [0.60, 
1.47] 
1 1,478 1.11 [0.83, 
1.50] 
 
3 2,227 1.46 [0.59, 
3.65] 
 
Simple phobia 1 1,178 0.63 [0.40, 
0.99]* 
 
0 - - 2 1,471 0.77 [0.58, 
1.01] 
 
ADNOS 0 - - 0 - - 1 293 1.38 [0.36, 
5.24] 
 
Any anxiety disorder 1 1,478 1.11[0.83, 
1.47] 
3 13,020 1.76 [1.14, 
2.72]** 
 
3 1,423 1.16 [0.66, 
2.03] 
 
Any psychiatric 
disorder 
2 1,894 1.22 [0.83, 
1.78] 
 
2 12,234 1.40 [0.87, 
2.24] 
 
2 2,584 1.10 [0.22, 
5.60] 
 
                                                          
a
 k = number of studies 
Note. * p ≤ .05; ** p ≤ .01; *** p ≤ .001 
I
2
 <  50% for: Current OCD, panic disorder, and agoraphobia; 12 month BPAD/mania/hypomania; Lifetime GAD, OCD, 
agoraphobia, social phobia, simple phobia, panic disorder, ADNOS, major depression, BPAD/mania/hypomania, dysthymic disorder, 
Any Mood Disorder.  
BPAD = Bipolar Affective Disorder; GAD = Generalised Anxiety Disorder; OCD = Obsessive Compulsive Disorder; PTSD = Post-
Traumatic Stress Disorder; ADNOS = Anxiety Disorder Not Otherwise Specified. 
 
 
 
 Table 4 Gender differences in current prevalence of common psychiatric disorders 
  Males   Females  
  
 
k
10
 
 
 
N  
 
            
 
Odds Ratio [M-H, Random, 
95% CI] 
  
 
k 
 
 
N  
 
 
Odds Ratio [M-H, 
Random, 95% CI] 
 
Mood 
Disorders 
      
Major 
depression 
4 6,
79
4 
0.96 [0.74, 1.25] 
 
6 21,
712 
1.38 [0.96, 1.97] 
 
Dysthymic 
disorder 
1 1,
20
8 
0.97 [0.50, 1.90] 
 
1 270 2.23 [0.84, 5.95] 
 
BPAD/mania/
hypomania 
2 1,
62
4 
1.56 [0.80, 3.04] 
 
1 270 3.16 [0.93, 10.76] 
 
Any Mood 
Disorder 
1 1,
20
8 
0.73 [0.46, 1.15] 
 
1 270 2.22 [1.18, 4.18]** 
 
Anxiety 
Disorders 
      
GAD 1 1,
20
8 
0.84 [0.52, 1.36] 
 
1 270 1.33 [0.64, 2.76] 
 
Panic disorder 1 1,
20
8 
1.18 [0.58, 2.41] 
 
1 270 1.30 [0.45, 3.78] 
 
OCD  1 1,
20
8 
0.62 [0.18, 2.08] 
 
1 270 3.67 [0.51, 26.60] 
 
Agoraphobia 1 1,
20
8 
1.77 [0.77, 4.06] 
 
1 270 0.50 [0.06, 4.17] 
 
Social phobia 1 1,
20
8 
13.20 [1.37, 127.47]* 
 
1 270 3.62 [0.22, 58.77] 
 
PTSD 1 1,
20
8 
1.00 [0.66, 1.51] 
 
1 270 1.44 [0.80, 2.61] 
 
Any anxiety 
disorder 
1 1,
20
8 
0.98 [0.70, 1.37] 
 
1 270 1.45 [0.81, 2.58] 
 
Any 
psychiatric 
disorder 
2 1,
62
4 
1.11 [0.61, 2.01] 
 
1 270 1.90 [1.05, 3.44]* 
 
Note. * p ≤ .05; ** p ≤ .01; *** p ≤ .001 
I
2
 <  50% for male rates of BPAD/mania/hypomania, and Any Psychiatric Disorder.   
BPAD = Bipolar Affective Disorder; GAD = Generalised Anxiety Disorder; OCD = Obsessive Compulsive 
Disorder; PTSD = Post-Traumatic Stress Disorder. 
 
Highlights 
                                                          
10
 k = number of studies 
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 Overall, mood and anxiety disorders were not elevated in the Indigenous populations 
examined 
 Disorder risk varied by several factors, such as gender, disorder type, and 
measurement 
 Indigenous people had significantly lower rates of Simple Phobias 
 Indigenous Australians had higher rates of Social Phobia and Bipolar Affective 
Disorder 
 
 
